These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3368751)

  • 1. Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis. Chemotaxis, phagocytosis and opsonized effect of PSS sera on normal granulocytes.
    Sipos A; Czirják L; Lörincz G; Szegedi G
    Scand J Rheumatol; 1988; 17(1):43-50. PubMed ID: 3368751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of anti-granulocyte antibodies by chemiluminescence.
    Hadley A; Holburn AM
    Clin Lab Haematol; 1984; 6(4):351-61. PubMed ID: 6525802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-platelet antibodies against gpIIb/IIIa in systemic sclerosis.
    Czirják L; Molnár I; Csipö I; Szabolcs M; Mihály A; Szegedi G
    Clin Exp Rheumatol; 1994; 12(5):527-9. PubMed ID: 7842534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.
    Hadley AG; Poole GD; Amphlett NW; Lucas GF
    Clin Lab Haematol; 1992; 14(4):315-26. PubMed ID: 1478011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-granulocyte opsonic activity and autoimmune neutropenia.
    Hadley AG; Holburn AM; Bunch C; Chapel H
    Br J Haematol; 1986 Jul; 63(3):581-9. PubMed ID: 3524659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function of monocytes in patients with systemic sclerosis.
    Czirják L; Dankó K; Zeher M; Lukács K; Szegedi G
    Acta Med Hung; 1988; 45(1):53-61. PubMed ID: 3045745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus.
    Hadley AG; Byron MA; Chapel HM; Bunch C; Holburn AM
    Br J Haematol; 1987 Jan; 65(1):61-5. PubMed ID: 3545279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elution of granulocyte and platelet antibodies.
    Helmerhorst FM; van Oss CJ; Bruynes EC; Engelfriet CP; von dem Borne AE
    Vox Sang; 1982; 43(4):196-204. PubMed ID: 6182693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.
    Anderson DC; Miller LJ; Schmalstieg FC; Rothlein R; Springer TA
    J Immunol; 1986 Jul; 137(1):15-27. PubMed ID: 3519773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of granulocyte antibodies on granulocyte function.
    Bux J; Dickmann JO; Stockert U; Mueller-Eckhardt C
    Vox Sang; 1993; 64(4):220-5. PubMed ID: 8517050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evans syndrome: characterization of the responsible autoantibodies.
    Pegels JG; Helmerhorst FM; van Leeuwen EF; van de Plas-van Dalen C; Engelfriet CP; von dem Borne AE
    Br J Haematol; 1982 Jul; 51(3):445-50. PubMed ID: 7104228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytotoxic and phagocytotoxic activity in progressive systemic sclerosis.
    Pruzanski W; Lee P; Willshire A; Gladman D; Keystone EC
    J Rheumatol; 1983 Feb; 10(1):55-60. PubMed ID: 6842486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin M antiplatelet autoantibodies from mice immunized with rat platelets induce thrombocytopenia and platelet function impairment.
    Detalle L; Su D; van Rooijen N; Coutelier JP
    Exp Biol Med (Maywood); 2010 Dec; 235(12):1464-71. PubMed ID: 21127343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxic autoantibodies in progressive systemic sclerosis.
    Herrmann K; Schaller J; Haustein UF; Baldauf C; Kiessig S
    Arch Dermatol Res; 1988; 280(7):399-404. PubMed ID: 3264691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of granulocytes and monocytes in primary biliary and alcoholic cirrhosis.
    Blussé van Oud A; Janssens AR; Leijh PC; van Furth R
    Clin Exp Immunol; 1985 Dec; 62(3):724-31. PubMed ID: 4085152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell and platelet autoantibodies in scleroderma.
    Girelli G; Sorgi ML; Conti L; Arista C; Giacomello A; Gandolfo GM; Zoppini A
    Clin Exp Rheumatol; 1993; 11(3):347-8. PubMed ID: 8353994
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-interleukin-6 autoantibodies in rheumatic diseases. Increased frequency in the sera of patients with systemic sclerosis.
    Takemura H; Suzuki H; Yoshizaki K; Ogata A; Yuhara T; Akama T; Yamane K; Kashiwagi H
    Arthritis Rheum; 1992 Aug; 35(8):940-3. PubMed ID: 1642659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemiluminescence assay for detection of anti-platelet antibodies.
    Menitove JE; Frenzke ME; Braem SW; Aster RH
    Klin Wochenschr; 1982 Jun; 60(11):567-9. PubMed ID: 7109496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.